During the past decade, Duke Center for Smoking Cessation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke Center for Smoking Cessation" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator and "Philip Morris USA, Inc." with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Duke Center for Smoking Cessation" are "Nicotine Dependence" (2 trials), "Cigarette Smoking" (1 trials) and "Smoking Cessation" (1 trials). Many other conditions were trialed in "Duke Center for Smoking Cessation" in a lesser frequency.

Most popular intervention types in "Duke Center for Smoking Cessation" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Chantix" (1 trials), "Ganaxolone" (1 trials), "Nicotine Patch" (1 trials), "Nicotine patches" (1 trials) and "Zyban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duke Center for Smoking Cessation" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Duke Center for Smoking Cessation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Duke Center for Smoking Cessation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Duke Center for Smoking Cessation, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".